Client News

Marinomed Biotech AG announces positive data demonstrating Carragelose efficacy against SARS-CoV-2 variants

ADOCIA Announces First Quarter 2021 Financial Results

XPhyto Signs German Distribution, Storage and Logistics Agreement for 25-Minute COVID-19 PCR Test

Abivax Hosting Key Opinion Leader Webinar on ABX464 for the Treatment of Ulcerative Colitis

Abivax completes induction treatment of last patient in ABX464 phase 2b clinical study in ulcerative colitis

Abivax publishes data of ABX464 induction and long-term maintenance phase 2a ulcerative colitis study in the prestigious journal “Gastroenterology”

Newron announces AGM 2021 result

LINDIS Biotech Reports Successful Initiation of Clinical Phase I Dose Escalation Study with the Trifunctional Antibody CATUMAXOMAB for Treatment of Non-Muscle-Invasive Bladder Cancer

Atriva Therapeutics Doses First Patient in Phase II RESPIRE trial in COVID-19

Newron announces AGM 2021 result